Home » Prices » LON:VCT

Victrex plc LON:VCT

Today's live share price, quote history, chart & news

Price:
20.66 GBP
Change:
+0.44 (2.18%)
Key Stats
Price open
Previous close 20.22
Market cap 0
Volume 0
Day high 22.62
Day low 18.47
Year high 25.74
Year low 16.45
Year to date change -14.98%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Victrex plc

Victrex was part of Imperial Chemical Industries (ICI) until a management buyout that took place in 1993. After incorporation, Victrex started operations with just 60 employees. Victrex’s specialization in the production of PEEK polymer and selling it to the industrial market led to exponential expansion. In 1995, Victrex floated its shares on the London Stock Exchange, and the company’s new name became Victrex Plc.

The company delegates its operations to several subsidiaries that each serve a specific segment of the market. Primarily, the company manufactures and distributes proprietary PEEK polymers to customers from all over the world. The PEEK polymer materials are essential for correcting knee, spine, dental, and orthopedic problems. Additionally, the company offers solutions that facilitate the proper application of medical devices and their manufacturing. Typical customers for Victrex’s products and services are medical markets, aerospace, electronics, and engineering markets. The company has its headquarters in Thornton Cleveleys, U.K.

Company information

Company name
Victrex Plc
Exchange
Sector
Process Industries
Industry
Chemicals: Major Diversified
Employees
N.A
CEO
Jakob O. Sigurðsson
Address
Victrex Technology Centre, Thornton Cleveleys, Lancashire, FY5
Country
United Kingdom
Contact information
44.1253.897700
Website
http://victrex.com

Related companies

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.